SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages.
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages.
复制标题
DOI:
10.1126/scitranslmed.abm9151
复制
发表时间:
2022-12-07
影响因子:
17.1
通讯作者:
McLaughlin, Tracey L.
中科院分区:
文献类型:
--
作者:
Martinez-Colon, Giovanny J.;Ratnasiri, Kalani;Chen, Heping;Jiang, Sizun;Zanley, Elizabeth;Rustagi, Arjun;Verma, Renu;Chen, Han;Andrews, Jason R.;Mertz, Kirsten D.;Tzankov, Alexandar;Azagury, Dan;Boyd, Jack;Nolan, Garry P.;Schuerch, Christian M.;Matter, Matthias S.;Blish, Catherine A.;McLaughlin, Tracey L.
Obesity, characterized by chronic low-grade inflammation of the adipose tissue, is associated with adverse coronavirus disease 2019 (COVID-19) outcomes, yet the underlying mechanism is unknown. To explore whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of adipose tissue contributes to pathogenesis, we evaluated COVID-19 autopsy cases and deeply profiled the response of adipose tissue to SARS-CoV-2 infection in vitro. In COVID-19 autopsy cases, we identified SARS-CoV-2 RNA in adipocytes with an associated inflammatory infiltrate. We identified two distinct cellular targets of infection: adipocytes and a subset of inflammatory adipose tissue-resident macrophages. Mature adipocytes were permissive to SARS-CoV-2 infection; although macrophages were abortively infected, SARS-CoV-2 initiated inflammatory responses within both the infected macrophages and bystander preadipocytes. These data suggest that SARS-CoV-2 infection of adipose tissue could contribute to COVID-19 severity through replication of virus within adipocytes and through induction of local and systemic inflammation driven by infection of adipose tissue-resident macrophages. SARS-CoV-2 is capable of infecting human adipose tissue and drives inflammation.
登录
查看更多内容
影响因子:
2.3
作者:
Acet Ozturk, Nilufer Aylin;Ursavas, Ahmet;Karadag, Mehmet
通讯作者:
Karadag, Mehmet
DOI:
10.1186/s10020-020-00230-x
发表时间:
2020-10-29
期刊:
Molecular medicine (Cambridge, Mass.)
影响因子:
--
作者:
Chen Y;Wang J;Liu C;Su L;Zhang D;Fan J;Yang Y;Xiao M;Xie J;Xu Y;Li Y;Zhang S
通讯作者:
Zhang S
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
7.4
作者:
Blot M;Bour JB;Quenot JP;Bourredjem A;Nguyen M;Guy J;Monier S;Georges M;Large A;Dargent A;Guilhem A;Mouries-Martin S;Barben J;Bouhemad B;Charles PE;Chavanet P;Binquet C;Piroth L;LYMPHONIE study group
通讯作者:
LYMPHONIE study group
DOI:
10.1038/s41366-021-00984-2
发表时间:
2022-01
期刊:
International journal of obesity (2005)
影响因子:
--
作者:
Bellae Papannarao J;Schwenke DO;Manning P;Katare R
通讯作者:
Katare R